Expertise in
11
conditions

Anne M. Griffiths

555 University Ave, M5G 1X8, 
Toronto, ON, CA 
Expertise in
11
conditions
555 University Ave, M5G 1X8, 
Toronto, ON, CA 

Overview

Anne Griffiths practices practicing medicine in Toronto, Canada.

Ms. Griffiths is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Colitis, Endoscopy, and Colonoscopy.

She is actively involved in clinical research, co-authoring 278 peer reviewed articles and participating in 7 clinical trials.

Gender

Female

Locations

555 University Ave, M5G 1X8, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis
A Multicenter, Open-Label PK Study of Mirikizumab in Pediatric Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Completed
Publish Date: March 26, 2024
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
Manipulating the Microbiome in IBD by Antibiotics and Fecal Microbiota Transplantation (FMT): a Randomized Controlled Trial
Manipulating the Microbiome in IBD by Antibiotics and Fecal Microbiota Transplantation (FMT): a Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: October 08, 2021
Intervention Type: Drug
Study Drugs: Vancomycin, Amoxycillin, Doxycyline, Ciprofloxacin, Methylprednisolone, Metronidazole
Study Phase: Not Applicable
A Pragmatic Randomized Controlled Trial on High Dose Vitamin D to Prevent Relapses of Crohn's Disease in Children
A Pragmatic Randomized Controlled Trial on High Dose Vitamin D to Prevent Relapses of Crohn's Disease in Children
Enrollment Status: Unknown
Publish Date: September 23, 2020
Intervention Type: Drug
Study Drug: Cholecalciferol
Study Phase: Phase 3
Randomized Controlled Trial of High Dose Vitamin D in Children With Newly Diagnosed Crohn's Disease for the Prevention of Relapses
Randomized Controlled Trial of High Dose Vitamin D in Children With Newly Diagnosed Crohn's Disease for the Prevention of Relapses
Enrollment Status: Completed
Publish Date: September 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
Enrollment Status: Completed
Publish Date: May 31, 2019
Intervention Type: Biological
View 6 Less Clinical Trials

277 Total Publications

Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update.
Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update.
Journal: Journal of Crohn's & colitis
Published: August 20, 2026

Frequently Asked Questions about Anne M. Griffiths

Is Anne M. Griffiths a top-rated expert for Crohn's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Anne M. Griffiths is classified as an Elite expert for Crohn's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anne M. Griffiths participate in research or clinical trials?

Yes. Anne M. Griffiths has published 277 articles and abstracts on conditions like Crohn's Disease. You can view a list of Anne M. Griffiths's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Griffiths's expertise for a condition
ConditionClose
    View All 9 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile